Colgate-Palmolive Stock Slips Below 50-Day SMA: Time to Be Cautious? Zacks Equity Research Aug 19, 2026 CL slips below its 50-day SMA as U.S. softness, competition and rising costs weigh despite solid Q2 growth and global momentum.
CL's Q2 Revenues Rise 4.9%: Can Growth Hold Amid Global Volatility? Zacks Equity Research Aug 18, 2026 Colgate's Q2 revenues rise 4.9% as emerging markets, Europe and Hill's drive growth, but U.S. weakness and rising costs cloud the second-half outlook.
Why Colgate-Palmolive (CL) is a Top Growth Stock for the Long-Term Zacks Equity Research Aug 18, 2026 The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
KMB Cuts 2026 Outlook as China Diaper Disruption Clouds Growth View Zacks Equity Research Aug 14, 2026 KMB cuts its 2026 outlook as China diaper disruption weighs on growth, while productivity and volume-mix gains offer some support.
BJ or CL: Which Is the Better Value Stock Right Now? Zacks Equity Research Aug 12, 2026 BJ vs. CL: Which Stock Is the Better Value Option?
4 Consumer Staples Stocks to Watch Amid Ongoing Industry Pressures Swati Prasad Aug 12, 2026 Despite cost pressures and spending volatility, CL, KMB, CHD and BJ are using strategic initiatives and operational efficiencies to drive growth.
Here's Why Colgate-Palmolive (CL) is a Strong Momentum Stock Zacks Equity Research Aug 12, 2026 Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Colgate Q2 Earnings Beat Estimates on Strong Margins, Sales Rise 4.9% Zacks Equity Research Jul 31, 2026 CL's Q2 earnings beat as organic sales, productivity and margin gains offset higher brand investment, while Latin America led regional growth.
Pre-Market Trading Up in Final Session of the Week Mark Vickery Jul 31, 2026 Despite some mid-week turbulence, we're trading fairly even with where we were as of mid-day Monday.
